TickerFacts.

A business in context

VERA research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-23 · 8022 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-09-15 · 0001859453-26-000015

  2. 8-K · Current report

    Report date 2026-09-15 · 0001193125-26-391280 · Items 7.01,8.01,9.01

  3. 4 · Ownership change

    Report date 2026-09-11 · 0001861684-26-000006

  4. 4 · Ownership change

    Report date 2026-09-02 · 0001859453-26-000014

  5. 4/A · Ownership change

    Report date 2026-07-07 · 0001859453-26-000013

  6. 4/A · Ownership change

    Report date 2026-06-23 · 0001859453-26-000012

  7. 4/A · Ownership change

    Report date 2026-05-12 · 0001859453-26-000011

  8. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-342380

  9. 8-K · Current report

    Report date 2026-08-10 · 0001193125-26-342335 · Items 2.02,9.01

  10. 4 · Ownership change

    Report date 2026-08-03 · 0002145711-26-000002

  11. 4 · Ownership change

    Report date 2026-07-07 · 0001859453-26-000010

  12. 8-K · Current report

    Report date 2026-07-09 · 0001193125-26-299165 · Items 5.02

  13. 8-K · Current report

    Report date 2026-07-07 · 0001193125-26-297211 · Items 8.01

  14. 8-K · Current report

    Report date 2026-06-02 · 0001193125-26-252475 · Items 8.01

  15. 8-K · Current report

    Report date 2026-05-21 · 0001193125-26-239559 · Items 5.07

  16. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-212143

  17. 8-K · Current report

    Report date 2026-05-07 · 0001193125-26-210351 · Items 2.02,9.01

  18. DEF 14A · Proxy statement

    Report date 2026-05-21 · 0001140361-26-014002

  19. 8-K · Current report

    Report date 2026-03-05 · 0001193125-26-098783 · Items 5.02

  20. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-077442

  21. 8-K · Current report

    Report date 2026-02-26 · 0001193125-26-073421 · Items 2.02,9.01

  22. 8-K · Current report

    Report date 2025-12-16 · 0001193125-25-323298 · Items 5.02

  23. 8-K · Current report

    Report date 2025-12-09 · 0001193125-25-314430 · Items 8.01,9.01

  24. 8-K · Current report

    Report date 2025-11-25 · 0001193125-25-300647 · Items 5.02

  25. 8-K · Current report

    Report date 2025-11-06 · 0001193125-25-268331 · Items 8.01,9.01

  26. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-266881

  27. 8-K · Current report

    Report date 2025-11-05 · 0001193125-25-265799 · Items 2.02,9.01

  28. 8-K · Current report

    Report date 2025-08-05 · 0001193125-25-173591 · Items 1.01,1.02,9.01

  29. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000950170-25-103022

  30. 8-K · Current report

    Report date 2025-08-05 · 0000950170-25-102399 · Items 2.02,9.01

  31. 8-K · Current report

    Report date 2025-06-02 · 0001193125-25-133730 · Items 1.01,2.03,9.01

  32. 8-K · Current report

    Report date 2025-06-02 · 0001193125-25-132736 · Items 7.01,8.01,9.01

  33. 8-K · Current report

    Report date 2025-05-14 · 0000950170-25-074446 · Items 5.07

  34. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-064733

  35. 8-K · Current report

    Report date 2025-05-06 · 0000950170-25-063975 · Items 2.02,9.01

  36. DEF 14A · Proxy statement

    Report date 2025-05-14 · 0001140361-25-012034

  37. 10-K · Annual report

    Report date 2024-12-31 · 0000950170-25-029969

  38. 8-K · Current report

    Report date 2025-02-26 · 0000950170-25-027337 · Items 2.02,9.01

  39. 8-K · Current report

    Report date 2025-01-13 · 0001193125-25-005010 · Items 7.01,9.01

  40. SC 13G/A · Ownership disclosure

    0001493152-24-045861

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-23 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 14 transaction rows14SGrant / award: 2 transaction rows2AExercise / conversion: 12 transaction rows12MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

28 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-09-15
2026-09-17
Fordyce Marshall
10b5-1 checkbox reported
S · Sale
Disposed
Class A Common Stock18500.037.0
2026-09-15
2026-09-17
Fordyce Marshall
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Class A Common Stock18500.02.9
2026-09-15
2026-09-17
Fordyce Marshall
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
18500.00.0
2026-09-11
2026-09-14
Young Joseph RM · Exercise / conversion
Acquired
Class A Common Stock5000.03.94
2026-09-11
2026-09-14
Young Joseph RM · Exercise / conversion
Disposed
Stock Option (right to buy)
Derivative security
5000.00.0
2026-09-02
2026-09-04
Fordyce Marshall
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Class A Common Stock18500.02.9
2026-09-02
2026-09-04
Fordyce Marshall
10b5-1 checkbox reported
S · Sale
Disposed
Class A Common Stock18500.035.12
2026-09-02
2026-09-04
Fordyce Marshall
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
18500.00.0
2026-08-03
2026-08-05
Boman Nancy LeeA · Grant / award
Acquired
Class A Common Stock44987.00.0
2026-08-03
2026-08-05
Boman Nancy LeeA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
63011.00.0
2026-07-07
2026-08-12 · Amendment
Fordyce Marshall
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Class A Common Stock46250.02.9
2026-07-07
2026-08-12 · Amendment
Fordyce Marshall
10b5-1 checkbox reported
S · Sale
Disposed
Class A Common Stock1000.040.78
2026-07-07
2026-08-12 · Amendment
Fordyce Marshall
10b5-1 checkbox reported
S · Sale
Disposed
Class A Common Stock2200.043.59
2026-07-07
2026-08-12 · Amendment
Fordyce Marshall
10b5-1 checkbox reported
S · Sale
Disposed
Class A Common Stock10500.042.86
2026-07-07
2026-08-12 · Amendment
Fordyce Marshall
10b5-1 checkbox reported
S · Sale
Disposed
Class A Common Stock32550.042.07
2026-07-07
2026-08-12 · Amendment
Fordyce Marshall
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
46250.00.0
2026-07-07
2026-07-09
Fordyce Marshall
10b5-1 checkbox reported
S · Sale
Disposed
Class A Common Stock2200.043.59
2026-07-07
2026-07-09
Fordyce Marshall
10b5-1 checkbox reported
S · Sale
Disposed
Class A Common Stock32550.042.07
2026-07-07
2026-07-09
Fordyce Marshall
10b5-1 checkbox reported
S · Sale
Disposed
Class A Common Stock1000.040.78
2026-07-07
2026-07-09
Fordyce Marshall
10b5-1 checkbox reported
S · Sale
Disposed
Class A Common Stock10500.042.86
2026-06-23
2026-08-12 · Amendment
Fordyce Marshall
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Class A Common Stock18500.02.9
2026-06-23
2026-08-12 · Amendment
Fordyce Marshall
10b5-1 checkbox reported
S · Sale
Disposed
Class A Common Stock88.038.43
2026-06-23
2026-08-12 · Amendment
Fordyce Marshall
10b5-1 checkbox reported
S · Sale
Disposed
Class A Common Stock18412.037.93
2026-06-23
2026-08-12 · Amendment
Fordyce Marshall
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
18500.00.0
2026-05-12
2026-08-12 · Amendment
Fordyce Marshall
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Class A Common Stock18500.02.9
2026-05-12
2026-08-12 · Amendment
Fordyce Marshall
10b5-1 checkbox reported
S · Sale
Disposed
Class A Common Stock4281.037.09
2026-05-12
2026-08-12 · Amendment
Fordyce Marshall
10b5-1 checkbox reported
S · Sale
Disposed
Class A Common Stock14219.036.64
2026-05-12
2026-08-12 · Amendment
Fordyce Marshall
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
18500.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-10-23 · 1658 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001831828Vera Therapeutics, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-23 · 1197 checked identities; 0 unavailable records

Search names and former names

    Revenue in constant purchasing power

    USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

    No USD annual revenue periods with complete CPI coverage are available. Non-USD statements are not converted with U.S. CPI.

    Bureau of Labor Statistics · retrieved 2026-10-23 · 9 selected series; gaps remain missing

    Explore the CPI history ↗